| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q9MYD9 | MHC class II antigen; Fragment; | HLA-DRB1; | NULL | 88 | human |
| A0A087WXN3 | BTB/POZ domain-containing protein 2; Fragment; | BTBD2; | NULL | 116 | human |
| Q6NSH7 | EEF1A1 protein; | EEF1A1; | NULL | 111 | human |
| Q8N8W3 | cDNA FLJ38763 fis, clone KIDNE2014119; | NULL | NULL | 261 | human |
| Q9H3L7 | My002 protein; | NULL | NULL | 212 | human |
| Q96CT6 | C12orf10 protein; Fragment; | C12orf10; | NULL | 322 | human |
| Q8NH31 | Seven transmembrane helix receptor; | NULL | NULL | 346 | human |
| Q9MYF2 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| Q9UK36 | Sodium/bile acid cotransporter; Fragment; | NULL | NULL | 37 | human |
| A8K6N9 | cDNA FLJ77153, highly similar to Homo sapiens calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma (CAMK2G), transcript variant 3, mRNA; | NULL | NULL | 518 | human |
| A8K7K0 | cDNA FLJ78111, highly similar to Homo sapiens regulator of G-protein signalling 18 (RGS18), mRNA; | NULL | NULL | 235 | human |
| A8K2S1 | cDNA FLJ75258, highly similar to Homo sapiens phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA; | NULL | NULL | 749 | human |
| Q860R3 | MHC class I antigen; Fragment; | HLA-A; | NULL | 91 | human |
| Q9H287 | Serologically defined breast cancer antigen NY-BR-18; Fragment; | NULL | NULL | 132 | human |
| A8K1G1 | cDNA FLJ76703, highly similar to Homo sapiens regulator of G-protein signaling 9L; RGS9; | NULL | NP_003826.2; | 674 | human |
| A8K6Z5 | cDNA FLJ78719, highly similar to Homo sapiens scavenger receptor class F, member 1, transcript variant 1, mRNA; | NULL | NP_003684.2; | 830 | human |
| Q8HWQ2 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| A8K7X9 | cDNA FLJ76922, highly similar to Homo sapiens zinc finger protein 272 (ZNF272), mRNA; | NULL | NULL | 562 | human |
| Q96LK1 | cDNA FLJ25424 fis, clone TST04169; | NULL | NP_536356.3; | 328 | human |
| A8K0D0 | cDNA FLJ76696; | NULL | NULL | 253 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |